- Did you mean
- vaccines preventie disease
Search results - 11 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
papillomavirus (HPV) vaccine (Cervarix, GSK, Rixensart, Belgium) (1). The study completes and strengthens the evidence of the high level of effectiveness of primary cervical cancer prevention by HPV vaccination ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron. Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en ...
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.
chronic diseases are at increased risk of complications following infection. It remains, however, unknown to what extend they are protected against vaccine-preventable diseases. We assessed seroprevalence ...
QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ+ T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge InfectionImage
novel vaccines to prevent T. gondii infections in livestock species and humans. Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart ...
Diphtheria in Belgium: 2010-2017.
decades thanks to the use of an effective vaccine and a high level of vaccination coverage. However, the disease has still not been eradicated and continues to occur in all of Europe. In order to prevent ...
Vaccine preventable bacterial diseases in Belgium: monitoring of general population immunity and pregnancy vaccination strategies
Monitoring Pregnancy vaccination strategies vaccine preventable diseases Abstract: Diphtheria, tetanus and pertussis are three serious infectious diseases caused by bacteria and that can be prevented by ...
Vaccine effectiveness estimates in preventing laboratory-confirmed mild and moderate-to-severe influenza in the Belgian population during the last 3 seasons.
POPULATION Seasons Surveillance vaccine Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Service: Maladies virales Virale ziekten ...
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
5 months of isoniazid preventive therapy, unless they had completed treatment for tuberculosis disease within 3 years before randomisation. Participants were randomly assigned (1:1) in blocks of four by ...
DNA vaccines against tuberculosis.
cells, Th1 cytokines and cytotoxic T lymphocytes) and was protective in mouse and guinea pig models of mycobacterial disease. Therefore, DNA vaccination holds promise as an effective means of preventing ...
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mindset of the manufacturer.
sometimes a lengthy process. Sometimes more than one year should be taken into account between the intention of putting a vaccine on the market and the first available commercial batch. Since OCABR in EU is ...